Journal article
Early Treatment with Pegylated Interferon Lambda for Covid-19
Abstract
BACKGROUND: The efficacy of a single dose of pegylated interferon lambda in preventing clinical events among outpatients with acute symptomatic coronavirus disease 2019 (Covid-19) is unclear.
METHODS: We conducted a randomized, controlled, adaptive platform trial involving predominantly vaccinated adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brazil and Canada. Outpatients who presented with an acute …
Authors
Reis G; Moreira Silva EAS; Medeiros Silva DC; Thabane L; Campos VHS; Ferreira TS; Santos CVQ; Nogueira AMR; Almeida APFG; Savassi LCM
Journal
The New England Journal of Medicine, Vol. 388, No. 6, pp. 518–528
Publisher
Massachusetts Medical Society
Publication Date
February 9, 2023
DOI
10.1056/nejmoa2209760
ISSN
0028-4793